DEVELOPMENT OF LYMPHOID HYPERPLASIA IN TRANSGENIC MICE EXPRESSING THE HIV TAT GENE

被引:31
|
作者
VELLUTINI, C
HORSCHOWSKI, N
PHILIPPON, V
GAMBARELLI, D
NAVE, KA
FILIPPI, P
机构
[1] INSERM,U372,VIROL LAB,F-13276 MARSEILLE 09,FRANCE
[2] CHU TIMONE,HEMATOL LAB,MARSEILLE 05,FRANCE
[3] CHU TIMONE,ANAT PATHOL LAB,MARSEILLE 05,FRANCE
[4] UNIV HEIDELBERG,ZMBH,D-69120 HEIDELBERG,GERMANY
关键词
D O I
10.1089/aid.1995.11.21
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During HIV infection, individuals experience multiorgan disorders such as adenopathy, splenomegaly, and lung and brain diseases. There is an increasing body of evidence that the HIV trans-activating tat gene product possesses multiple activities. First, it can activate several cellular genes; second, in its extracellular soluble form, it plays the role of growth factor in some cells such as Kaposi's sarcoma cells. Thus, we introduced the HIV tat gene, under the control of the cellular proteolipoprotein promoter, into the germline of mice and demonstrate that, when expressed, the tat gene product induces lymphoid hyperplasia in spleen, lymph nodes, and lung, as is observed in AIDS patients, but not in the brain or testes. Our findings indicate that HIV, through some of its genes, directly participates in the pathogenesis of AIDS.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 50 条
  • [21] Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders
    Zucchini, Silvia
    Pittaluga, Anna
    Brocca-Cofano, Egidio
    Summa, Maria
    Fabris, Marina
    De Michele, Rita
    Bonaccorsi, Angela
    Busatto, Graziella
    Barbanti-Brodano, Giuseppe
    Altavilla, Giuseppe
    Verlengia, Gianluca
    Cifelli, Pierangelo
    Corallini, Alfredo
    Caputo, Antonella
    Simonato, Michele
    NEUROBIOLOGY OF DISEASE, 2013, 55 : 110 - 119
  • [22] Inducible and reversible β-cell autoimmunity and hyperplasia in transgenic mice expressing a conditional oncogene
    Berkovich, I
    Efrat, S
    DIABETES, 2001, 50 (10) : 2260 - 2267
  • [23] HIV-1 Tat increases oxidant burden in the lungs of transgenic mice
    Cota-Gomez, Adela
    Flores, Ariana C.
    Ling, Xiao-Feng
    Varella-Garcia, Marileila
    Flores, Sonia C.
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (09) : 1697 - 1707
  • [24] Positive Inotropic and Lusitropic Effects of Acetylcysteine on HIV-Tat Transgenic Mice
    Chen, Fangping
    Lewis, William
    Xie, Sherry
    Finkel, Mitchell S.
    FASEB JOURNAL, 2010, 24
  • [25] Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice
    Fitting, Sylvia
    Scoggins, Krista L.
    Xu, Ruqiang
    Dever, Seth M.
    Knapp, Pamela E.
    Dewey, William L.
    Hauser, Kurt F.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 689 (1-3) : 96 - 103
  • [26] Aberrant regulation of cytokines in HIV-1 TAT(72)-transgenic mice
    Garza, HH
    Prakash, O
    Carr, DJJ
    JOURNAL OF IMMUNOLOGY, 1996, 156 (10): : 3631 - 3637
  • [27] Lymphoid Hyperplasia and Lymphoma in Transgenic Mice Expressing the Small Non-Coding RNA, EBER1 of Epstein-Barr Virus
    Repellin, Claire E.
    Tsimbouri, Penelope M.
    Philbey, Adrian W.
    Wilson, Joanna B.
    PLOS ONE, 2010, 5 (02):
  • [28] Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene
    Saadi-Kheddouci, S
    Berrebi, D
    Romagnolo, B
    Cluzeaud, F
    Peuchmaur, M
    Kahn, A
    Vandewalle, A
    Perret, C
    ONCOGENE, 2001, 20 (42) : 5972 - 5981
  • [29] MAMMARY DEVELOPMENT AND MILK SECRETION IN TRANSGENIC MICE EXPRESSING THE SHEEP BETA-LACTOGLOBULIN GENE
    WILDE, CJ
    CLARK, AJ
    KERR, MA
    KNIGHT, CH
    MCCLENAGHAN, M
    SIMONS, JP
    BIOCHEMICAL JOURNAL, 1992, 284 : 717 - 720
  • [30] Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene
    Sihem Saadi-Kheddouci
    Dominique Berrebi
    Béatrice Romagnolo
    Françoise Cluzeaud
    Michel Peuchmaur
    Axel Kahn
    Alain Vandewalle
    Christine Perret
    Oncogene, 2001, 20 : 5972 - 5981